BCL-2 proteins correspond to a structurally, functionally and phylogenetically heterogeneous group of regulators that play crucial roles in the life and death of animal cells. Some of these regulators also represent therapeutic targets in human diseases including cancer. In the omics era, there is great need for easy data retrieval and fast analysis of the molecular players involved in cell death. In this article, we present generic and specific computational resources (such as the reference database BCL2DB) as well as bioinformatics tools that can be used to investigate BCL-2 homologs and BH3-only proteins.
Introduction
BCL-2 proteins correspond to a still growing group of regulators which play a major role in cell death (by apoptosis) in animals (1,2) . These proteins are among the most studied in cell biology and represent therapeutic targets especially in cancers (3) (4) (5) . This protein group is formed by a family of homologs (structurally and evolutionarily) related to BCL-2 and characterized by the presence of one to four BCL-2 Homology motifs (BH1 to BH4), and by a collection of diverse proteins that harbor only the BH3 motif (6,7) . BCL-2 homologous proteins can function as either anti-apoptotic (such as BCL-2 and BCL-xL) or pro-apoptotic factors (like BAX and BAK) based on their influence on the permeabilization of the mitochondrial outer membrane, a key event in apoptosis induction. BH3-only proteins are pro-apoptotic proteins that act upstream of the mitochondrial events, initiating apoptosis in response to developmental cues or intracellular damages. Three decades of research have elucidated the complex interplay of interactions between the various subgroups of BCL-2 proteins (8). So-called 'activator' BH3-only proteins (e.g. BIM and tBID) can directly activate BAX or BAK by a transient physical interaction leading to their conversion into membrane-associated dimers that further oligomerize into cytochrome-c permeable pores. In contrast to activator BH3-only proteins, 'sensitizer' BH3-only proteins (like BAD and NOXA) trigger mitochondrial permeabilization by docking their α-helical BH3 region into a hydrophobic groove present on the surface of anti-apoptotic BCL-2 homologs, thereby releasing BAX/BAK or activator BH3only proteins. Anti-apoptotic BCL-2 proteins can also prevent mitochondrial cytochrome-c release by interacting with and inhibiting BAX and BAK. Mechanistic aspects of the regulation of the intrinsic (i.e., mitochondrial) pathway of apoptosis by BCL-2 proteins have been extensively addressed elsewhere and the reader is referred to comprehensive reviews on the topic (1, [9] [10] [11] [12] 8) .
Several lines of evidence have progressively complicated the four-digit classification system described above (pro-versus anti-apoptotic BCL-2 homologs, sensitizer versus direct activator BH3-only proteins) (13). First, from a functional perspective, anti-apoptotic BCL-2 proteins can be switched (by cleavage or alternative splicing) to death-inducing factors in certain conditions or in certain cells (14-17), whereas pro-apoptotic BCL-2 proteins were sometimes reported to protect against apoptosis (18). Moreover, multiple BCL-2 family members have been described as being either pro-or anti-apoptotic at the time of their initial characterization (19-26). Most importantly, there is a growing realization that both anti-and pro-apoptotic BCL-2 proteins seem to play non-apoptotic roles (partly or completely) distinct from their roles in cell death, like regulation of mitochondrial morphology (27), calcium homeostasis, cellular metabolism and autophagy (28,29). As a corollary, BCL-2 proteins were shown to exert functions at subcellular sites other than the outer mitochondrial membrane (such as the endoplasmic reticulum or peroxisomes). Second, at the structural level, BCL-2 homologous proteins (in their soluble forms) were all found to fold as compact α-helical bundles (30,31). Extensive sequence divergence and insertions and deletions (indels) of amino acid sequences during evolution represent distinctive features of this protein domain (32,7), which bears resemblance to globular bacterial toxins and viral regulators (33) (34) (35) . In contrast, BH3 motifs occur both in wellstudied (or 'classical') BH3-only proteins (BIM, BAD, BMF, HRK, NOXA, PUMA and EGL-1), which are intrinsically disordered proteins (36), and in globular BCL-2 homologous proteins and a series of unrelated proteins that have (or are predicted to have) a defined tertiary structure. A more nuanced picture have therefore started to emerge, wherein the BH3 motif could represent a novel type of protein-protein interaction module (i.e., a 'short linear motif' or a 'molecular recognition feature') that spreads beyond BCL-2 proteins (6). Last, phylogenetically, the BCL-2 family of homologs evolved under a dynamic regime during animal history, with lineage-specific diversification events leading to species-specific gene repertoires (37,32,7). Although some genes (such as BAK or BCL2L1/BCL-xL) appear to be conserved over relatively large evolutionary distances, others are more divergent (such as those forming the BCL-2 gene complement in early-branching metazoans (38,39)) or are found only in restricted taxa (like BFL-1/BCL2A1 in mammals or BCL-WAV in fishes and reptiles (37,40)). A number of BCL-2-related genes were also acquired by viruses from cellular hosts through gene transfer events (41). Due to their presence in proteins from families with distinct molecular functions and evolutionary histories, BH3 motifs have probably had a more complex evolution than BCL-2 homologs, undergoing duplication-divergence dynamics, but also random/convergent evolution and exon shuffling (6).
The multiplicity and (structural, functional and phylogenetic) heterogeneity of proteins forming the contemporary BCL-2 clan poses specific challenges to researchers trying to investigate their structure-function relationships, interaction and regulatory networks. Historically, most studies on BCL-2 sequences and structures have been performed through laborious searches and have focused only on a limited set of genes and proteins. However, nowadays, the highthroughput technologies, including Next-Generation Sequencing (NGS), produce a huge volume of raw data ranging from whole-genome, exome, RNA-Seq or targeted NGS, to gene expression levels (DNA microarrays) and three-dimensional structures (e.g. of BCL-2 proteins in complex with specific ligands). This ever-increasing flow of available data needs to be adequately clustered and processed to extract useful information and to allow 'BCL-2-ologists' to browse them efficiently. Here, we describe (1) general (2) specialized and (3) dedicated computational resources and tools that can be used to investigate BCL-2 and BH3-containing proteins and (4) illustrate how to perform searches with the reference database BCL2DB (https://bcl2db.ibcp.fr/) (42). Given the many databases created worldwide (43), a comprehensive coverage of all available tools and resources is not feasible. Only five classes of specialized databases will be considered that are of general interest to 'BCL-2-ologists': (i) signature databases; (ii); molecular interaction and post-translational modification (PTM) databases (iii) structural databases; (iv) (comparative) genomic databases; (v) transcript databases. Part of the knowledge contained within general and specialized databases has been incorporated into databases dedicated to proteins more specifically involved in cell death regulation or execution, including BCL-2 proteins. These databases have been developed for slightly different purposes, but generally without a focus on the BCL-2 group, except BCL2DB.
Materials
All the databases and in silico tools mentioned in this chapter are listed in Table 1 .
Methods

General databases
An overview on how to collect information from the databases described in this article is given in Figure 1 .
1. As a first step, if the sequence of interest has been collected from bibliographic data, use keyword searches in any of the large-spectrum databases of the International Nucleotide Sequence Database Collaboration (INSDC) (see Note 1) to get general information. Primary information can be collected rather easily using these databanks as long as the sequence of interest is properly annotated.
2. For the characterization of novel sequences (e.g. issued from sequencing programs) or unannotated protein-coding genes, perform sequence similarity searches using sequence comparison algorithms such as BLAST or FASTA to identify highly similar sequences (see Note 2).
Specialized databases
Specialized databases (also called secondary or derived databases) can have multiple characteristics, but they usually draw upon external primary information (deposited in primary databanks) to provide consistent analytical results, with various (often high) levels of curation . Some of this data has been re-packaged to facilitate studies especially in the cancer field (see for instance the Cancer Genome Atlas initiative, the CBio Portal for Cancer Genomics and the Catalogue Of Somatic Mutations In Cancer, COSMIC).
Dedicated databases
Several dedicated databases have become obsolete (such as the Apoptosis Database ApoDB, DeathBase and AGIS, the Apoptosis Gene Information System), whereas novel databases have been created (from THANATOS, which is basically a catalog of proteins involved in cell death, to more sophisticated or oriented databases as listed below). 
The BCL-2 Database
BCL2DB is a database and web portal giving rapid access to up-to-date knowledge about BCL-2 family proteins and BH3-only proteins. It holds a collection of annotated sequences and structures of BCL-2-related molecules in a standardized format and provides a variety of tools and external links.
1. First, explore the homepage central menu to choose the functionalities and specific tools relevant to your study. Before navigating any further in the website, we highly recommend that the reader familiarizes with the classification used in BCL2DB (Nomenclature Page) (see Note 16). Sequences available in these three databanks are identical.
Use the
2. While these programs constitute a great approach to rapidly find pairs of conserved orthologs in many species, BLAST-like methods suffer from several limitations. In our experience with BCL-2 family members, BLAST results are heavily biased towards highly covered taxa (if no taxonomic filter is applied), the closest hit may not always be the nearest phylogenetic neighbor and remote homologs can frequently be missed.
Moreover, these techniques are not suited to mine sequence databanks in search of BH motifs, which correspond to relatively small and sometimes degenerate stretches of amino acids (like the BH3 and BH4 motifs (7) ).
3. In the case of BCL-2 homologs and BH3-bearing proteins, there are four such motifs:
BH1, BH2, BH3 and/or BH4.
4. Note that some tools tend to aggregate BCL-2 proteins with their binding partners (e.g.
BAG family chaperones).
5.
These repositories should not be considered as redundant as they differ in several aspects: the methodology used to produce the signatures can be different (e.g. regular expressions, pairwise sequence comparison clustering or profiles) as can be the primary source of sequences (e.g. Swiss-Prot, UniProtKB/TrEMBL or the NCBI RefSeq collection). There are also differences in the information used to classify the proteins (e.g. functional conserved motifs, structural data from the CATH and SCOP resources).
6. When the interest is being focused towards a given species or phylogenetic lineage, we recommend to conduct searches directly in the dedicated genomic databases (often provided by the consortium that generated the data), as they are regularly updated and provide the most accurate information. 17. These elements are marked as "F" and "C" in the table cells. "R" is a repertoire that gives information to analyze conserved/variable alignment positions, residue frequencies and Shannon entropy.
18. UniProtKB is mined on a regular basis using a set of proprietary profile HMMs that were implemented to specifically recognize the different BCL-2 family orthology groups and the various clusters of BH3-bearing proteins. If a given sequences does not match any of the constituted groups, it is assigned as 'unclassified'. 19 . In MSA, identical residues (*) are in red, strongly similar residues (:) in green, weakly similar residues (.) in blue and unalike residues in black. These alignments can be interactively edited using the provided 'EditAlignment' applet.
20. These options are marked as "D" (download) and "V" (view) in the table cells.
21.
In main instances, it makes no sense to align full-length BH3-only sequences with that of full-length BCL-2 homologous proteins, especially to drive conclusions about their phylogenetic relationships as these proteins do not share a same ancestor. 22 . This tool is based on home-made BH1-BH4 motif profiles with improved sensitivity and specificity compared to signatures available on signature-based databases.
23. Be careful to use a correctly formatted/supported FASTA sequence header (e.g. ref|accession). If you have doubt, simply use >accession as sequence header and be sure to use a different accession for each sequence. Upload only text files (.txt) and not files in MS Office binary format (such as .doc or .xls files). 
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